Afatinib Completed Phase 2 Trials for Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00875433Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours